Profile
Full Name
Intellia Therapeutics, Inc.Ticker Symbol
NTLAExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
May 6, 2016Indexes
Not includedWebsite
http://www.intelliatx.comEmployees
403Key Details
Price
$6.86(-6.79%)
Market cap
$710.13M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$57.88M(+59.55% YoY)
Annual EPS
-$5.25(+3.14% YoY)
PE ratio
-
Next earnings date
May 9, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Intellia Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 5, 25 HC Wainwright & Co.
BuyMar 4, 25 Truist Securities
BuyFeb 28, 25 Wells Fargo
OverweightFeb 28, 25 JP Morgan
NeutralFeb 28, 25 Citigroup
NeutralFeb 28, 25 Chardan Capital
BuyFeb 28, 25 Barclays
OverweightJan 27, 25 Morgan Stanley
Equal-WeightJan 14, 25 Goldman Sachs
NeutralJan 13, 25 Oppenheimer
OutperformInstitutional Ownership
- What is the ticker symbol for Intellia Therapeutics?
- Does Intellia Therapeutics pay dividends?
- What sector is Intellia Therapeutics in?
- What industry is Intellia Therapeutics in?
- What country is Intellia Therapeutics based in?
- When did Intellia Therapeutics go public?
- Is Intellia Therapeutics in the S&P 500?
- Is Intellia Therapeutics in the NASDAQ 100?
- Is Intellia Therapeutics in the Dow Jones?
- When was Intellia Therapeutics's last earnings report?
- When does Intellia Therapeutics report earnings?
- Should I buy Intellia Therapeutics stock now?
What is the ticker symbol for Intellia Therapeutics?
The ticker symbol for Intellia Therapeutics is NASDAQ:NTLA
Does Intellia Therapeutics pay dividends?
No, Intellia Therapeutics does not pay dividends
What sector is Intellia Therapeutics in?
Intellia Therapeutics is in the Healthcare sector
What industry is Intellia Therapeutics in?
Intellia Therapeutics is in the Biotechnology industry
What country is Intellia Therapeutics based in?
Intellia Therapeutics is headquartered in United States
When did Intellia Therapeutics go public?
Intellia Therapeutics's initial public offering (IPO) was on May 6, 2016
Is Intellia Therapeutics in the S&P 500?
No, Intellia Therapeutics is not included in the S&P 500 index
Is Intellia Therapeutics in the NASDAQ 100?
No, Intellia Therapeutics is not included in the NASDAQ 100 index
Is Intellia Therapeutics in the Dow Jones?
No, Intellia Therapeutics is not included in the Dow Jones index
When was Intellia Therapeutics's last earnings report?
Intellia Therapeutics's most recent earnings report was on Feb 27, 2025
When does Intellia Therapeutics report earnings?
The next expected earnings date for Intellia Therapeutics is May 9, 2025
Should I buy Intellia Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions